Has Sara Parnell received payments from drug or device companies?

Yes. Drug and device makers reported $2,937 in general payments to Sara Parnell across 156 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Sara Parnell did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Sara Parnell come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Sara Parnell

Psychiatric/Mental Health · Ilion, NYNPI 1669032850

Payments from drug & device makers

$2,937in general payments, 2019–2025

Across 156 payments — averaging $18.83 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Indivior Inc.$543
AbbVie$469
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$462
Lundbeck LLC$250
Otsuka America Pharmaceutical, Inc.$226
Johnson & Johnson$208
plus $779 from 14 others

What the payments were for

Food & beverage$2,937100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Indivior Inc.	33	$543
AbbVie	22	$469
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	26	$462
Lundbeck LLC	16	$250
Otsuka America Pharmaceutical, Inc.	13	$226
Johnson & Johnson	6	$208
Teva Pharmaceuticals USA, Inc.	5	$184
Sunovion Pharmaceuticals Inc.	11	$173
Alkermes, Inc.	9	$163
Supernus Pharmaceuticals, Inc.	3	$39
Gilead	1	$32
Vanda Pharmaceuticals Inc.	1	$29
Neurocrine Biosciences, Inc.	2	$27
Avanir Pharmaceuticals, Inc.	1	$22
AstraZeneca	1	$21
Hikma Pharmaceuticals USA	1	$21
Corium, LLC	2	$20
Oxford Immunotec USA Inc	1	$19
Axsome Therapeutics, Inc.	1	$16
Lilly USA, LLC	1	$16

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,937 in reported general payments places this provider in the 85th percentile of 2,385 psychiatric/mental health providers in New York.

See all psychiatric/mental health providers in New York →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
VraylarCariprazine Hcl	30	$41,530
Bupropion XlBupropion Hcl	35	$803
Aripiprazole	12	$521
Buspirone Hcl	23	$445
Venlafaxine Hcl ErVenlafaxine Hcl	17	$412
Propranolol Hcl	34	$374
Trazodone Hcl	52	$365
Mirtazapine	18	$302
Duloxetine Hcl	22	$294
Bupropion Hcl SrBupropion Hcl	12	$282
Hydroxyzine Hcl	12	$147
Sertraline Hcl	28	$129
Paroxetine Hcl	11	$121
Alprazolam	33	$119
Clonazepam	31	$111

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
AbbVieVraylar	$469	$41,53030 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,385 psychiatric/mental health providers in New York.

Other psychiatric/mental health in Ilion

Glenn HannDansville$1.3M
Tammy RussoNiskayuna$568K
Carrie EdickSchenectady$484K
Eric SpronzCentereach$448K
Terry Jo Brooks-DevlinTonawanda$176K
Kevin SiewersStaten Island$155K
Daniel BreeyearNiskayuna$149K
Mary OlsonNew York$142K
Elijah StevensBinghamton$131K
Kayanna JonasFar Rockaway$93K

See the full list for New York →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →